Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
research and development
Fierce Biotech
AZ restarts £300M UK investment, but Merck not budging
AstraZeneca will resume a £300 million investment program in the U.K., seven months after freezing plans in frustration at drug pricing negotiations.
James Waldron
Apr 29, 2026 10:01am
Fierce Biotech
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
Antibody expert Bio X Cell debuts Beijing distribution center
Feb 11, 2025 9:42am
Amid restructuring, Novartis plots layoffs in development group
Apr 9, 2024 3:22pm
Phlow and nonprofit USP team to open drug development lab
Dec 13, 2022 9:50am
The White House unveiled a new biotech-minded executive order
Sep 13, 2022 10:53am
